Overview

Update
Total Equity Funding
$70.8M in 6 Rounds from 9 Investors
Most Recent Funding
$13.8M Private Equity on July 2, 2012
Headquarters:
Morrisville, North Carolina
Description:
To groundbreaking research that leads to the improved safety and efficacy of vaccines and therapeutics.
Founders:
Categories:
Biopharma, Therapeutics, Nanotechnology
Website:
http://www.liquidia.com
Social:

Company Details

Update

Liquidia Technologies is developing highly precise particle-based vaccines and therapeutics for the prevention and treatment of human disease. Combining a deep understanding of particle-based drug development with breakthrough small molecule and biological therapeutics, Liquidia is engineering vaccines and therapies that have the potential to dramatically improve the quality of human life.

Funding Rounds (7) - $73.8M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jul, 2012$13.8M / Private Equity0
Mar, 2011$10M / Venture2
Jul, 2010$5M / Series C5
Jan, 2010$20M / Series C5
Dec, 2009$3M / Grant1
Mar, 2007$16M / Series B3
Jun, 2006$6M / Series A3

Current Team (9)

Update

Board Members and Advisors (3)

Update

Offices/Locations (1)

Update
  • Headquarters

    419 Davis Drive

    Suite 100

    Morrisville, North Carolina 27560

    United States

Past Team (2)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos